Abbott Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Abbott Laboratories
ABT Stock  USD 125.92  0.26  0.21%   
Analyzing historical trends in various income statement and balance sheet accounts from Abbott Laboratories' financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Abbott Laboratories' valuation are summarized below:
Gross Profit
24.7 B
Profit Margin
0.3188
Market Capitalization
219.2 B
Enterprise Value Revenue
5.1233
Revenue
43.8 B
There are currently one hundred twenty fundamental signals for Abbott Laboratories that can be evaluated and compared over time across rivals. All traders should validate Abbott Laboratories' prevailing fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 180.4 B in 2026. Enterprise Value is likely to gain to about 188.9 B in 2026

Abbott Laboratories Total Revenue

50.65 Billion

Check Abbott Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Abbott Laboratories' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.9 B, Interest Expense of 515.6 M or Selling General Administrative of 14.1 B, as well as many indicators such as Price To Sales Ratio of 4.41, Dividend Yield of 0.0395 or PTB Ratio of 2.63. Abbott financial statements analysis is a perfect complement when working with Abbott Laboratories Valuation or Volatility modules.
  
Build AI portfolio with Abbott Stock
Check out the analysis of Abbott Laboratories Correlation against competitors.
For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.

Abbott Laboratories Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets98.3 B93.6 B64.5 B
Slightly volatile
Short and Long Term Debt Total10 B17.6 B15.5 B
Slightly volatile
Other Current Liabilities9.2 B8.8 B6.5 B
Slightly volatile
Total Current Liabilities8.5 B16.3 B11 B
Slightly volatile
Total Stockholder Equity57.6 B54.8 B31.6 B
Slightly volatile
Property Plant And Equipment Net14.2 B13.5 B8.6 B
Slightly volatile
Net Debt6 B8.8 B8.5 B
Slightly volatile
Retained Earnings57.1 B54.4 B29.9 B
Slightly volatile
Cash9.2 B8.8 B7.4 B
Slightly volatile
Non Current Assets Total69.7 B66.4 B43.8 B
Slightly volatile
Non Currrent Assets Other18.6 B17.7 B5.3 B
Slightly volatile
Cash And Short Term Investments9.6 B9.2 B8.3 B
Pretty Stable
Net Receivables8.4 B8 B5.6 B
Slightly volatile
Common Stock Shares Outstanding1.3 B1.6 B1.7 B
Very volatile
Liabilities And Stockholders Equity98.3 B93.6 B64.5 B
Slightly volatile
Non Current Liabilities Total12.1 B22.3 B20.5 B
Pretty Stable
Inventory7.5 B7.1 B4.3 B
Slightly volatile
Other Current Assets2.3 B3 B2.6 B
Pretty Stable
Total Liabilities20.4 B38.5 B31.1 B
Slightly volatile
Property Plant And Equipment Gross27.5 B26.2 B12.4 B
Slightly volatile
Total Current Assets28.6 B27.2 B20.9 B
Slightly volatile
Short Term Debt2.1 B2 B1.9 B
Pretty Stable
Accounts Payable5.1 B4.8 B2.8 B
Slightly volatile
Current Deferred Revenue148.8 M156.6 M301.8 M
Slightly volatile
Common Stock Total Equity29.8 B28.4 B19 B
Slightly volatile
Short Term Investments745.6 M403.6 M922.9 M
Slightly volatile
Common Stock30.4 B28.9 B19.1 B
Slightly volatile
Intangible Assets8.6 B7.6 B9.9 B
Pretty Stable
Other Liabilities5.7 B7.6 B6.5 B
Slightly volatile
Other Assets18.6 B17.7 B5.6 B
Slightly volatile
Long Term Debt12.1 B14.5 B13.6 B
Slightly volatile
Property Plant Equipment8.1 B13.5 B8.2 B
Slightly volatile
Good Will15.9 B26.6 B17.8 B
Slightly volatile
Noncontrolling Interest In Consolidated Entity163.8 M251.8 M167.7 M
Slightly volatile
Retained Earnings Total Equity27.2 B40.5 B27.4 B
Slightly volatile
Long Term Debt Total15.6 B14.5 B14.4 B
Slightly volatile
Long Term Investments1.1 B1 B1.1 B
Very volatile
Non Current Liabilities Other4.2 B3.1 B5 B
Slightly volatile
Short and Long Term Debt1 B1.7 B896.7 M
Slightly volatile
Cash And Equivalents6.8 B6.9 B11.9 B
Slightly volatile
Net Invested Capital59.4 B71.1 B57.3 B
Very volatile
Net Working Capital9.5 B10.9 B9.9 B
Slightly volatile
Capital Stock26.8 B28.9 B24.4 B
Slightly volatile
Capital Lease Obligations990.2 M1 B836.3 M
Slightly volatile

Abbott Laboratories Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization3.9 B3.7 B2.7 B
Slightly volatile
Selling General Administrative14.1 B13.5 B9.6 B
Slightly volatile
Total Revenue50.7 B48.2 B32.8 B
Slightly volatile
Gross Profit25.7 B24.5 B16.4 B
Slightly volatile
Other Operating Expenses42.4 B40.4 B26.7 B
Slightly volatile
Operating Income3.9 B7.8 B4.7 B
Slightly volatile
EBIT9.2 B8.8 B5 B
Slightly volatile
EBITDA13.1 B12.5 B7.7 B
Slightly volatile
Cost Of Revenue24.9 B23.7 B15.2 B
Slightly volatile
Total Operating Expenses17.5 B16.6 B11.5 B
Slightly volatile
Income Before Tax8.5 B8.1 B4.9 B
Slightly volatile
Net Income16.2 B15.4 B5.7 B
Slightly volatile
Research Development2.2 B3.2 B2.2 B
Slightly volatile
Net Income Applicable To Common Shares16.2 B15.4 B5.9 B
Slightly volatile
Minority Interest264.4 M251.8 M151.4 M
Slightly volatile
Net Income From Continuing Ops16.2 B15.4 B5.8 B
Slightly volatile
Non Recurring397 M331.2 M312.6 M
Very volatile
Discontinued Operations20.5 M21.6 M312.5 M
Slightly volatile
Interest Income279.9 M395.6 M199.7 M
Slightly volatile
Reconciled Depreciation2.3 B2.9 B2.9 B
Slightly volatile

Abbott Laboratories Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow4 B7.3 B4.9 B
Slightly volatile
Begin Period Cash Flow8.3 B7.9 B7 B
Slightly volatile
Depreciation1.9 B3.7 B2.6 B
Slightly volatile
Capital Expenditures1.3 B2.5 B1.6 B
Slightly volatile
Total Cash From Operating Activities5.3 B9.8 B6.4 B
Slightly volatile
Net Income16.2 B15.4 B5.6 B
Slightly volatile
End Period Cash Flow9.2 B8.8 B7.3 B
Slightly volatile
Stock Based Compensation812.6 M774 M477.3 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio4.414.23.6393
Slightly volatile
Dividend Yield0.03950.02250.0253
Slightly volatile
PTB Ratio2.633.73.6895
Slightly volatile
Days Sales Outstanding49.7854.2361.4573
Slightly volatile
Book Value Per Share26.1424.918.3571
Slightly volatile
Free Cash Flow Yield0.03540.03730.0515
Slightly volatile
Operating Cash Flow Per Share2.374.453.7058
Slightly volatile
Stock Based Compensation To Revenue0.00840.01440.0131
Slightly volatile
Capex To Depreciation1.070.790.7203
Pretty Stable
PB Ratio2.633.73.6895
Slightly volatile
EV To Sales4.584.373.8972
Slightly volatile
Free Cash Flow Per Share1.783.32.8033
Pretty Stable
ROIC0.150.110.0855
Pretty Stable
Inventory Turnover2.933.03.5398
Slightly volatile
Net Income Per Share7.316.973.1574
Slightly volatile
Days Of Inventory On Hand111126104
Slightly volatile
Payables Turnover5.344.426.2473
Slightly volatile
Sales General And Administrative To Revenue0.220.290.3102
Slightly volatile
Research And Ddevelopement To Revenue0.09280.07740.0729
Very volatile
Capex To Revenue0.07130.06050.0546
Very volatile
Cash Per Share4.354.144.8933
Very volatile
POCF Ratio21.6320.618.5948
Slightly volatile
Interest Coverage21.3413.0221.9557
Slightly volatile
Payout Ratio0.450.260.7121
Very volatile
Capex To Operating Cash Flow0.350.30.2859
Pretty Stable
PFCF Ratio14.3127.7625.0756
Slightly volatile
Days Payables Outstanding47.4566.8161.1817
Slightly volatile
Income Quality0.550.572.0786
Pretty Stable
ROE0.260.320.1703
Slightly volatile
EV To Operating Cash Flow22.4721.419.9051
Slightly volatile
PE Ratio17.1113.1536.5538
Very volatile
Return On Tangible Assets0.170.30.1393
Slightly volatile
EV To Free Cash Flow15.6428.8426.8856
Slightly volatile
Earnings Yield0.09270.07870.0551
Slightly volatile
Intangibles To Total Assets0.290.330.4047
Pretty Stable
Net Debt To EBITDA0.760.641.2132
Pretty Stable
Current Ratio1.241.51.8606
Slightly volatile
Receivables Turnover6.56.975.9688
Slightly volatile
Graham Number65.4262.3134.4662
Slightly volatile
Shareholders Equity Per Share26.0124.7717.9554
Slightly volatile
Debt To Equity0.40.290.5314
Pretty Stable
Capex Per Share0.651.150.9061
Slightly volatile
Revenue Per Share22.8921.818.7819
Slightly volatile
Interest Debt Per Share7.618.259.5297
Pretty Stable
Debt To Assets0.180.170.2426
Pretty Stable
Enterprise Value Over EBITDA17.7516.9117.0573
Slightly volatile
Short Term Coverage Ratios3.24.396.2567
Pretty Stable
Price Earnings Ratio17.1113.1536.5538
Very volatile
Operating Cycle179195168
Pretty Stable
Price Book Value Ratio2.633.73.6895
Slightly volatile
Days Of Payables Outstanding47.4566.8161.1817
Slightly volatile
Dividend Payout Ratio0.450.260.7121
Very volatile
Price To Operating Cash Flows Ratio21.6320.618.5948
Slightly volatile
Price To Free Cash Flows Ratio14.3127.7625.0756
Slightly volatile
Pretax Profit Margin0.210.190.1484
Slightly volatile
Ebt Per Ebit0.820.921.0453
Slightly volatile
Operating Profit Margin0.210.190.1536
Slightly volatile
Company Equity Multiplier1.731.542.0823
Slightly volatile
Long Term Debt To Capitalization0.180.190.2891
Pretty Stable
Total Debt To Capitalization0.260.220.3328
Pretty Stable
Return On Capital Employed0.110.120.1036
Very volatile
Debt Equity Ratio0.40.290.5314
Pretty Stable
Ebit Per Revenue0.210.190.1536
Slightly volatile
Quick Ratio0.971.111.4914
Slightly volatile
Dividend Paid And Capex Coverage Ratio1.891.631.6262
Pretty Stable
Net Income Per E B T1.811.721.0402
Slightly volatile
Cash Ratio0.310.480.6779
Pretty Stable
Cash Conversion Cycle121110108
Slightly volatile
Operating Cash Flow Sales Ratio0.230.2040.2009
Slightly volatile
Days Of Inventory Outstanding111126104
Slightly volatile
Days Of Sales Outstanding49.7854.2361.4573
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.540.670.7058
Very volatile
Cash Flow Coverage Ratios0.910.640.5602
Pretty Stable
Price To Book Ratio2.633.73.6895
Slightly volatile
Fixed Asset Turnover2.613.223.6911
Slightly volatile
Capital Expenditure Coverage Ratio2.983.493.8911
Very volatile
Price Cash Flow Ratio21.6320.618.5948
Slightly volatile
Enterprise Value Multiple17.7516.9117.0573
Slightly volatile
Debt Ratio0.180.170.2426
Pretty Stable
Cash Flow To Debt Ratio0.910.640.5602
Pretty Stable
Price Sales Ratio4.414.23.6393
Slightly volatile
Return On Assets0.130.190.0851
Slightly volatile
Asset Turnover0.830.590.5544
Very volatile
Net Profit Margin0.390.370.1653
Slightly volatile
Gross Profit Margin0.590.580.5124
Slightly volatile
Price Fair Value2.633.73.6895
Slightly volatile
Return On Equity0.260.320.1703
Slightly volatile

Abbott Laboratories Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap180.4 B171.8 B132.2 B
Slightly volatile
Enterprise Value188.9 B179.9 B140.4 B
Slightly volatile

Abbott Fundamental Market Drivers

Forward Price Earnings22.2222
Cash And Short Term Investments8 B

Abbott Upcoming Events

17th of April 2024
Upcoming Quarterly Report
View
18th of July 2024
Next Financial Report
View
31st of March 2024
Next Fiscal Quarter End
View
22nd of January 2025
Next Fiscal Year End
View
31st of December 2023
Last Quarter Report
View
31st of December 2023
Last Financial Announcement
View

About Abbott Laboratories Financial Statements

Abbott Laboratories shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Abbott Laboratories investors may analyze each financial statement separately, they are all interrelated. The changes in Abbott Laboratories' assets and liabilities, for example, are also reflected in the revenues and expenses on on Abbott Laboratories' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue156.6 M148.8 M
Total Revenue48.2 B50.7 B
Cost Of Revenue23.7 B24.9 B
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.29  0.22 
Research And Ddevelopement To Revenue 0.08  0.09 
Capex To Revenue 0.06  0.07 
Revenue Per Share 21.80  22.89 
Ebit Per Revenue 0.19  0.21 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Abbott Stock Analysis

When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY